JSW
IDXX icon

Journey Strategic Wealth’s Idexx Laboratories IDXX Stock Holding History

Journey Strategic Wealth’s Portfolio IDXX Stock Details IDXX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$250K Sell
445
-77
-15% -$49.4K 0.01% 648
2025
Q4 		$353K Sell
522
-18
-3% -$12.3K 0.01% 436
2025
Q3 		$345K Buy
540
+65
+14% +$39.5K 0.01% 418
2025
Q2 		$255K Buy
+475
New +$227K 0.01% 503

Other funds holding IDXX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
BAMCO Inc
BAMCO Inc New York $33.1B AUM 11.16% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Fundsmith LLP
Fundsmith LLP London, United Kingdom $12.8B AUM 6.9% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Journey Strategic Wealth's IDXX Position: Q1 2026 in Review

Journey Strategic Wealth reduced its Idexx Laboratories (IDXX) stake by 15% in Q1 2026, selling an estimated $49.4K and leaving 445 shares worth $250K. The position accounts for 0.01% of the portfolio, ranked #648.

Journey Strategic Wealth first reported a position in IDXX in Q2 2025 and has held it in 4 quarters since. The position peaked at $353K in Q4 2025. 1,312 funds tracked by Wall St. Rank hold IDXX as of Q1 2026.

  • Journey Strategic Wealth held 445 shares of Idexx Laboratories worth $250K as of Q1 2026.
  • Journey Strategic Wealth sold 77 Idexx Laboratories shares in Q1 2026, an estimated $49.4K.
  • Idexx Laboratories made up 0.01% of Journey Strategic Wealth's portfolio in Q1 2026, its #648 holding.
  • Journey Strategic Wealth first reported a position in Idexx Laboratories in Q2 2025 and has held it in 4 quarters since.
  • Journey Strategic Wealth's Idexx Laboratories position peaked at $353K in Q4 2025.
  • 1,312 funds tracked by Wall St. Rank held Idexx Laboratories as of Q1 2026.

Based on Journey Strategic Wealth's 13F filing for Q1 2026, filed 15 Apr 2026.